Cancer Institute of New Jersey at the Cooper University Hospital

Camden, New Jersey 08103-1489

0 studies enrolling now · 14 studies all time

What they study most

Anal Cancer, Bladder Cancer, Brain and Central Nervous System Tumors, Breast Cancer, Endometrial Cancer, Extragonadal Germ Cell Tumor, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Lymphoma, Malignant Mesothelioma, Prostate Cancer

Studies at this site

• Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer — Completed
• Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer — Stopped early
• Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer — Completed
• Combination Chemotherapy and Computer-Planned Radiation Therapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer — Completed
• Combination Chemotherapy in Treating Patients With Bladder Cancer — Completed
• Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer — Completed
• Surgery in Treating Patients With Prostate Cancer — Completed
• Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma — Completed
• Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer) — Completed
• Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors — Stopped early
• PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma — Completed
• Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus — Completed
• Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme — Completed
• Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer) — Completed